List of drugs in clinical trials

List of 10 ALK inhibitor drugs currently (or soon to be) in clinical trials:

Ariad AP26113
Astellas ASP-3026
Chugai Alectinib (filed NDA in Japan)
Nerviano NMS-E628. (Licensed by Ignyta and renamed RXDX-101)
Novartis LDK-378
Pfizer Crizotinib (FDA approved but several trials ongoing)
Pfizer PF-06463922
Tesaro TSR-011
Teva CEP-37440
Xcovery x-396

This entry was posted in alectinib - Alecensa from Chugai - Roche - GenenTech, brigatinib-Alunbrig from Takeda, CEP-37440, ceritinib - Zykadia from Novartis, crizotinib - Xalkori from Pfizer, NMS-E628, Potential Treatments, Research, RXDX-101 - entrectinib - by Ignyta, TSR-011 from Tesaro, X-396 - ensartinib from Xcovrery. Bookmark the permalink.

Leave a Reply